Immunomodulators for multiple sclerosis may ameliorate spinal bone loss
Irish Journal of Medical Science, 04/13/2012
McKenna MJ et al. – The observations suggest that immunomodulator therapy (IMT) may have a beneficial effect on spinal bone by an antiresorptive action. A prospective study of the effect of IMT on bone mineral density (BMD) and bone turnover is warranted.